Diplomate, American Board of Psychiatry & Neurology
1207 Carlsbad Village Drive, Suite R
Carlsbad, California 92007
Ph. (760) 434-2603 Fax (760) 434-3557
|Certifications:||Diplomate, American Board of Psychiatry and Neurology California License No.: G052545|
|1986 – Present||Private Practice of Adult and Adolescent Psychiatry, specializing in the psychotherapeutic and pharmacologic treatment of Depression, Anxiety, Panic, Bipolar Disorder, Anorexia, Bulimia, ADD, Chemical Dependency, and Behavioral Medicine.|
|11/5/2012||Author. “Successful Psychopharmacology: Evidence-Based Treatment Solutions for Achieving Remission – A Guide for Physicians, Mental Health Professionals, and Their Patients.” W. W. Norton & Company.|
|2007||Honored as “Teacher of the Year” by the United States Psychiatric and Mental Health Congress.|
|2001 – Present||Clinical Instructor, University of California, San Diego School of Medicine.|
|2003 – Present||Consulting Psychiatrist, NFL Player Assistance Program.|
|2003 – 2017||Consulting Psychiatrist, NFL San Diego Chargers.|
|2005 – Present||Consulting Psychiatrist, MLB San Diego Padres.|
|1997 – Present||Medical Director, Advancing Solutions Medical Research Institute.|
|1996 – 1998||Principle Investigator in Psychiatry, The Health Advance Institute.|
|1986 – Present||Lecturer on Psychiatric Issues throughout the United States and internationally,
including diagnosis and treatment of depression, anxiety, bipolar disorder, panic, OCD, ADD/ADHD, eating disorders, chemical dependency, psychopharmacology and psychotherapy – see attached list.
|1995 – Present||Expert Medical Reviewer, Medical Board of California.|
|1990 – Present||Guest Lecturer, U.C. San Diego School of Medicine.|
|1989 – 1991||Chief of Staff Charter/Alvarado Parkway Institute, La Mesa, California|
|1986 – 2005||Consulting Psychiatrist, Student Counseling Center,
University of San Diego San Diego, California
|1986 – 1989||Educator, Graduate Department of Psychology,
San Diego State University Psychiatric Diagnosis and Psychopharmacology)
|1993 – 1996||Chairman, Wellness Committee, CPC San Luis Rey Hospital Encinitas, California|
|1986 – 1995||Medical Director, Eating Disorders Treatment Program, Charter/Alvarado Parkway Institute, La Mesa, California|
|1988 – 1991||Member of Executive Committee, Chairman of the Case Management Conference, Charter/Alvarado Parkway Institute, La Mesa, California|
|1989||Member of the Internal Medicine, Special Services Supervisory Committee, Charter/Alvarado Parkway Institute, La Mesa, California|
|1983 – 1986||Residency, Department of Psychiatry, University of California
San Diego, CaliforniaSpecial Advanced Training in Consultation, Liaison and
Emergency Psychiatry98th Percentile Psychiatric Residents in Training
Examination (PRITE)Supervision of Residents in Emergency RoomSpecial Liaison to Departments of Neurology and Nephrology
|1982 – 1983||Internship, Department of Medicine, Georgetown University
Washington, D.C., Based at District of Columbia General Hospital
Primary responsibility for Patient Evaluation, Diagnosis,
Management and Treatment
|1978 – 1983||Vanderbilt University School of Medicine
Honors: Recipient of Beauchamp Award for Outstanding
Performance and Promise in PsychiatryAdvanced Training in Adult Psychiatry, St. Bartholomew’s
Medical Center, London, England
|1974 – 1978||Duke University
B.S. in Zoology and Psychology
Honors: Phi Beta Kappa, National Merit Scholar,
Magna Cum Laude
|Author. “Successful Psychopharmacology: Evidence-Based Treatment Solutions for Achieving Remission – A Guide for Physicians, Mental Health Professionals, and Their Patients.” W. W. Norton & Company. 11/5/2012.
Principle Investigator, Buspirone, Protocol CN 101-095, An Open-label, long-term, safety study of Transdermal Buspirone in the treatment of Anxious Outpatients, Bristol Myers-Squibb Company, 1997-1998.
Investigator – “Lilly’s Emotional and Physical Symptoms of Depression Study – Cymbalta.” Eli Lilly & Company, 2003-2005.Investigator, Examining Clinical Experience with Escitalopram in Depression Trial, Forrest Laboratories, 2002-2003.
Investigator, Citalopram HBR Clinical Experience Trial, Forrest Laboratories, 1998.
Co-Investigator, Wellbutrin SR, Protocol 208, An open, multi-site evaluation of Bupropion HCL Sustained Release to determine the clinical response, functional status and incidence of serious adverse events, Burroughs Wellcome Company, 1993.
|Sobel, SV, Faiman C.,
|Effect of haloperidol on sleep apnea. American Journal of Psychiatry, 142 (6): 775, 1985.|
|Sobel, Stephen V.||Effective Personalized Strategies for Treating Bipolar Disorder, Psychiatric Times. Vol. 29 No. 8 August 2, 2012|
|Sobel, Stephen V.||Psychiatric Issues: Cognitive Therapy for Anxiety and Depression, Recognizing Bipolar Disorder in Adolescence. Audio-Digest, Pediatrics, Vol. 56, Number 8, April 21, 2010.|
|Sobel, Stephen V.||Depression and Bipolar Disorder: Practical Principles for Pharmacologic Management. Behavioral Health Trends Journal. Vol. 18. May 2006, 7-16.|
|Sobel, Stephen V.||Anxiety Disorders: Using Medications to Maximal Advantage.
Behavioral Health Trends Journal. Vol. 17. June 2005, 17-25.
|Sobel, Stephen V.||“Psychopharmacology for the Psychotherapist.” Effective Approaches to Psychotherapy in the 21st Century Course. Mhsource.com, CME Inc., 2005.|
|Sobel, Stephen V.||“Psychopharmacology of Anxiety Disorders.” Anxiety Disorders: Assessment, Diagnosis and Treatment Course. Mhsource.com, CME Inc., 2005.|
|Sobel, Stephen V.||“Psychopharmacology of Depression and Bipolar Disorders.” Recognizing and Resolving Depressive Disorders Across the Life Cycle Course. Mhsource.com, CME Inc., 2005.|
|Sobel, Stephen V.||A Fresh Way to Manage Trauma. Current Psychiatry, 2004; 3(11), 100.|
|Sobel, Stephen V.||“Eating Disorders,” CME Resource 2004 – 15 credit hour course.|
|Sobel, Stephen V.||“Pharmacology of Depression and Bipolar Disorder.” Recognizing and Resolving Depressive Disorders Across the Life Cycle Course. Mhsource.com, CME, Inc., 2004.|
|Sobel, Stephen V.||“Pharmacology of Psychoses and ADHD” Psychopharmacology: An Update on Current Treatment Options Course. Mhsource.com. CME, Inc,. 2004.|
|Sobel, Stephen V.||Perplexing Psychiatric Problems, Audio-Digest, Family Practice, Vol. 51, Number 3, January 21, 2003.|
|Sobel, Stephen V.||Are We Undertreating Depression? Audio-Digest, Internal Medicine, Vol.
46, Number 16, August 21, 1999.
|Sobel, Stephen V.||Anxiety and Depression: Beyond Prozac. Anxiety Disorders: The Great
Medical Impostor. Audio-Digest, Internal Medicine, Vol. 45, Number 20,
October 15, 1998.
|Sobel, Stephen V.||Discussion on Depression. Journal watch, Vol. 9, Number 13,
July 1, 1998.
|Sobel, Stephen V.||Obsessive Compulsive Disorder. CME Online.
http:/www.comevu.com, July 1998.
|Sobel, Stephen V.||Psychiatrists’ Approach to Mental Illness, Depression, Panic Disorder, and OCD. Audio-Digest, Family Practice, Vol. 46, Number 8, February 8, 1998.|
|Sobel, Stephen V.||What’s New in the Treatment of Anorexia Nervosa and Bulimia.
Http:/www.medscape.com/clinical/medscape/womens health 9/96.
|Sobel, Stephen V.||Eating Disorders. Audio-Digest, Obstetrics/Gynecology, Vol. 42, Number 20, October 17, 1995.|
|Sobel, Stephen V.||The Multidisciplinary managed behavioral health care team model
guidelines for successful collaboration. Managed Behavioral Health Care, Volume II, 1994.
|References and further information/documentation available upon request.|